Sphere Fluidics Awarded European Trademark for Cyto-Mine
Sphere Fluidics was awarded its European Trademark for Cyto-Mine, a novel single cell assay system for rapid biologics discovery and development. “Excellent news. This adds to our growing IP portfolio and protects this key brand for Sphere Fluidics. We plan that the system it protects will ultimately be globally launched in a number of key market sectors” said Dr Frank F. Craig (CEO). “We are also launching news about our new system in China this week”, he said.